UltraSPECT

What UltraSPECT does

UltraSPECT, founded in 1999 and headquartered in Auburndale, Massachusetts with origins in Haifa, Israel, develops image reconstruction software for nuclear medicine imaging practices. The company's core proprietary technology, Wide Beam Reconstruction (WBR), is an iterative reconstruction algorithm that implements resolution recovery and adaptive noise control to resolve the sensitivity-resolution trade-off inherent in gamma cameras. WBR enables simultaneous reduction in radiopharmaceutical dose and scan time while maintaining or improving diagnostic image quality. The product suite comprises Xpress.Cardiac (half-dose or half-time cardiac SPECT), Xpress3.Cardiac (quarter-time/quarter-dose protocols), Xpress/Xact.Bone (oncology/bone imaging), and the UltraSPECT.gate DICOM-compliant hardware platform.

The software is vendor-neutral and compatible with 41 different gamma cameras and 12 workstations across all major manufacturers (GE, Philips, Siemens), allowing healthcare facilities to upgrade existing equipment rather than replace it. UltraSPECT's offerings are priced at 5-10% of the cost of a new gamma camera, positioning them as a capital-efficient upgrade path. The company distributes primarily through channel partnerships with 8 radiopharmaceutical pharmacies (Nuclear Diagnostic Products, HeartLight Pharmacy Services, PharmaLogic) and service organizations like BC Technical (125 field engineers) and Absolute Imaging Solutions. WBR received FDA approval in 2006 and is also approved in Europe and Asia; the company achieved ISO 13485:2016 certification in 2021.

UltraSPECT primarily serves U.S. hospitals and health systems, independent cardiology practices, freestanding imaging centers, and radiopharmaceutical suppliers. As of 2016, the company had installed 450+ units across 300+ health systems in 46 U.S. states, with over 200 units sold between 2013-2015 and double-digit annual revenue growth in the preceding years. Named customers include Duke University Medical Center, Mayo Clinic, St. Luke's-Roosevelt Hospital, Hamilton Cardiology Associates, Henry Ford Wyandotte Hospital, Robert Wood Johnson Physician Enterprise, and Firelands Regional Medical Center. The company is privately held with Yossi Srour as President and CEO, and has received investment from Giza Venture Capital.

Name

UltraSPECT

Legal name

UltraSPECT Inc.

Website

https://ultraspect.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

UltraSPECT develops FDA-approved image reconstruction software (Wide Beam Reconstruction) for nuclear medicine, enabling reduced radiation dose and scan time on existing gamma cameras. It serves U.S. hospitals, cardiology practices, and imaging centers through a channel partner model spanning 300+ health systems.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Irradiation Apparatus Manufacturing (334517)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

Keywords

• Nuclear medicine imaging
• Image reconstruction software
• Cardiac SPECT imaging
• Medical imaging software
• Radiation dose reduction

Headquarters

HQ city

Haifa

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Software/Technology Licensing: UltraSPECT licenses its WBR image reconstruction software to healthcare facilities. The software is sold as a software package that enhances existing gamma cameras. Pricing is described as a fraction (5-10%) of the cost of a new camera, making it highly cost-effective for facilities. Sales occur through direct purchasing or through radiopharmaceutical supply agreements with pharmacy partners.
2. Professional Services: Installation, application training, and service support are provided through partnerships (e.g., BC Technical field engineers and AIS). These may be bundled or sold alongside the core software product.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

UltraSPECT develops and licenses image reconstruction software for nuclear medicine gamma cameras and PET scanners. Its Wide Beam Reconstruction (WBR) technology enables healthcare facilities to perform cardiac and oncology SPECT imaging at half the radiopharmaceutical dose, half the scan time, or both, while maintaining or improving image quality. Products are vendor-neutral, working with existing cameras from all major manufacturers at 5-10% of the cost of a new camera.

Product overview

UltraSPECT offers a suite of image reconstruction products based on proprietary Wide Beam Reconstruction (WBR™) technology. The product portfolio consists of three core software products: Xpress.Cardiac for half-dose or half-time cardiac imaging, Xpress3.Cardiac for simultaneous reduced-dose and reduced-time cardiac imaging (supporting quarter protocols), and Xpress/Xact.Bone for half-dose/half-time bone and oncology imaging. All products leverage WBR™ iterative reconstruction algorithms to reduce radiation dose, shorten acquisition times, and increase diagnostic quality for nuclear medicine exams. The products are hardware-agnostic, working with existing gamma cameras regardless of manufacturer, model, or age, and are supported by the UltraSPECT.gate hardware platform for DICOM connectivity.

Differentiator

Problem solved

Functional benefit

Brands

• WBR (Wide Beam Reconstruction): Proprietary iterative reconstruction imaging algorithm that enables lower dose and shorter time imaging for nuclear medicine exams.
• Xpress.Cardiac
• Xpress3.Cardiac
• Xpress/Xact.Bone
• UltraSPECT.gate

Products and services

• Xpress.Cardiac Image reconstruction software enabling rest/stress cardiac SPECT imaging with either half the radiopharmaceutical dose or half the scan time compared to conventional acquisition techniques, based on WBR technology. For cardiology practices, hospitals, and imaging centers.
• Xpress3.Cardiac

Quantifiable outcome

• 77% of studies achieved radiation doses below 9 mSv using UltraSPECT half-dose protocol vs. 0% with conventional full-dose protocol
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core.

• BC TechnicalcoreImplementation/ SI/ Consulting Partner · 1 January 2016BC Technical is a diagnostic imaging service organization specializing in NM products and servicing over 2,000 NM, CT, MR and PET systems for 1,500 customers nationwide. The partnership was strengthened in 2016 to support UltraSPECT's growing installation base. BC Technical Field Engineers (125 engineers averaging 21+ years of experience) handle all UltraSPECT installations while Applications Specialists provide technologist and physician training. The partnership enables BC Technical to offer current-generation functionality on legacy NM systems.
• HeartLight Pharmacy ServicescoreChannel Partner/ Reseller/ Distributor · 1 January 2015HeartLight Pharmacy Services is an Ohio-based radiopharmaceutical provider offering UltraSPECT products as part of its HeartSafe Imaging initiative to help nuclear medicine facilities reduce SPECT radiation exposure and minimize scan time. HeartLight has locations in Lima, Columbus, and Dayton, Ohio. The partnership facilitated the 450th UltraSPECT installation at Firelands Regional Medical Center. HeartLight streamlines purchasing for facilities through their radiopharmaceutical supply agreements.
• American Society of Nuclear Cardiology (ASNC)coreStrategic or Co-development Partner · 3 March 2014UltraSPECT and ASNC partnered in 2014 to provide six ASNC Technologist Travel Awards of $1,200 each to enable deserving nuclear medicine technologists to attend the ASNC 2014 Annual Scientific Session in Boston. UltraSPECT sponsors the first annual ASNC Technologist Travel Award, demonstrating commitment to the ASNC community and dose-reduction mission. Selection criteria include interest in ASNC programs, participation in educational activities, and involvement in ASNC volunteer activities.
• Nuclear Diagnostic Products (NDP)coreChannel Partner/ Reseller/ Distributor · 1 January 2013NDP (Nuclear Diagnostic Products of Philadelphia, Inc.) is a radiopharmaceutical supplier that offers UltraSPECT products as part of its supply agreements with nuclear medicine facilities. Through this partnership, UltraSPECT extends its reach to NDP's customer base, enabling hospitals and practices like Hamilton Cardiology Associates and Berks Cardiologists to access low-dose imaging technology. NDP's owner Wayne Wong noted the partnership began early and was a trusted, growing relationship through 2016.
• PharmaLogiccoreChannel Partner/ Reseller/ Distributor · 1 January 2013PharmaLogic is a radiopharmaceutical provider offering UltraSPECT WBR software as part of its patient-centered supply approach since 2013. The partnership allows PharmaLogic to offer a low-dose, high-quality cardiac imaging solution to customers ahead of likely regulatory mandates. PharmaLogic's Don Widener noted the primary value to customers is cutting patient radiation exposure in half while also reducing technologist exposure, with impressive imaging capabilities particularly for patients with difficult body habitus.
• Absolute Imaging Solutions (AIS)coreChannel Partner/ Reseller/ Distributor · 1 January 2009AIS has partnered with UltraSPECT since 2009, packaging UltraSPECT's Xpress.Cardiac, Xpress3.Cardiac, and Xpress/Xact.Bone software with OEM Reconditioned Philips-ADAC-Siemens-GE cameras and the Mediso AnyScan S camera. AIS is ISO-13485 certified, serves major health systems, independent hospitals, VA Health system, and private practices. The partnership delivers combined camera and software solutions for dose reduction and quality patient care.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hermes Medical Solutions: Sweden-based developer of nuclear medicine image processing, reconstruction, and review software widely used in SPECT and PET workflows. Directly comparable to UltraSPECT as a vendor-neutral software layer sitting on top of OEM cameras, addressing the same cardiology and oncology imaging customers.
• Invia Medical Imaging Solutions: Provider of cardiac and nuclear medicine image analysis software, including Corridor 4DM SPECT and PET quantification tools. Competes head-to-head with UltraSPECT in nuclear cardiology software, serving the same hospital and cardiology practice customers with similar reconstruction and analysis capabilities.
• Segami Corporation: Specialist in nuclear medicine image processing software (Oasis line) for SPECT and PET, with a similar niche focus on vendor-neutral processing and review tools. Comparable to UltraSPECT as a smaller, focused nuclear medicine software vendor serving similar clinical workflows.
• Mirada Medical: Developer of medical image fusion, segmentation and quantification software used in nuclear medicine, radiation oncology and diagnostic imaging. Comparable to UltraSPECT in offering advanced image processing software that integrates with multi-vendor imaging hardware, including SPECT and PET.

Emerging players

• MIM Software: Medical imaging analysis software company focused on multi-modality workflows including nuclear medicine, radiotherapy and AI-driven contouring. Adjacent competitor with partial overlap in NM image processing and review, though broader in modality coverage than UltraSPECT.
• Spectrum Dynamics (Smart Medical): Specialist in advanced nuclear medicine hardware and software, including D-SPECT cardiac cameras and VERITON-CT SPECT/CT systems with embedded reconstruction. Emerging player pushing technological boundaries that could either validate or displace UltraSPECT's third-party software approach.

Broad incumbents

• Siemens Healthineers: Global OEM of SPECT and PET cameras (Symbia family) with embedded iterative reconstruction and a full nuclear medicine software stack. Comparable to UltraSPECT as a provider of nuclear medicine imaging solutions, though as part of a much broader imaging portfolio and with native camera integration.
• GE HealthCare: Global OEM of nuclear medicine cameras (NM/CT 870, Discovery NM family) and the Xeleris workstation with embedded reconstruction. Overlaps with UltraSPECT in nuclear medicine imaging software, particularly where GE bundles its own reconstruction into new systems competing against UltraSPECT's vendor-neutral upgrade story.
• Philips Healthcare: Major imaging OEM historically active in SPECT (now divested its nuclear medicine business) and a broad digital health portfolio. Relevant incumbent peer because Philips' past SPECT presence shaped the OEM competitive landscape that UltraSPECT still navigates today.
• Canon Medical Systems: OEM of nuclear medicine cameras (Cartesion, Symbia-procurement heritage) and owner of Mirada Medical's nuclear medicine software assets. Comparable to UltraSPECT as both an OEM competitor with embedded reconstruction and a software-only competitor through Mirada.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/129515947114802
• Xx.com/UltraSPECTinc
• LinkedInlinkedin.com/company/371906

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UltraSPECT